Oasys vs. Extreme H20 Xtra 59

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00477763

Enrollment

Registered

2007-05-24

Start date

2007-05-31

Completion date

2008-02-29

Last updated

2008-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Interventions

DRUGRestasis, Refresh Endura

1. Restasis 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening 2. Refresh Endura 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male or Female at least 19 years of age * Contact Lens Wearers * Patients with mild to moderate symptoms of dry eye

Exclusion criteria

* male or female younger than 19 years of age

Design outcomes

Primary

Measure	Time frame
comparing performance of contact lens	10 months

Secondary

Measure	Time frame
Dry eye	10 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026